Discovery on Target 2017 | Small Molecule Ubiquitin Protease (USP7) Inhibitors

from CHI Podcasts · host Cambridge Healthtech Podcasts

Tauseef Butt, CEO of Progenra Inc. speaks to CHI on September 8, 2017. Dr. Butt will be presenting during Immunomodulatory Small Molecules and Targeting the Ubiquitin Proteasome System, taking place this September 27-28 at Discovery on Target in Boston, MA. Topics include the benefits and challenges of immunomodulatory small molecules, Ubiquitin Protease (USP7) Inhibitors performance in animal models, Progenra’s discovery platform and their plans for developing other immunomodulatory strategies.

Episode metadata supplied by the publisher feed · Published Sep 14, 2017

Embed this episode

Attribution link and audio player

NOW PLAYING

Discovery on Target 2017 | Small Molecule Ubiquitin Protease (USP7) Inhibitors

0:00 10:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CHI Podcasts?

This episode is 10 minutes long.

When was this CHI Podcasts episode published?

This episode was published on September 14, 2017.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!